During the past decade, Pulmonary Associates of Richmond, Inc. conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 16 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pulmonary Associates of Richmond, Inc." #1 sponsor was "United Therapeutics" with 7 trials, followed by "Sunovion" with 6 trials sponsored, "Bellerophon Pulse Technologies" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Sunovion Respiratory Development Inc." with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pulmonary Associates of Richmond, Inc." #1 collaborator was "Lung Biotechnology PBC" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pulmonary Associates of Richmond, Inc." are "Chronic Obstructive Pulmonary Disease" (8 trials), "Pulmonary Hypertension" (6 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Interstitial Lung Disease" (4 trials) and "Asthma" (3 trials). Many other conditions were trialed in "Pulmonary Associates of Richmond, Inc." in a lesser frequency.

Most popular intervention types in "Pulmonary Associates of Richmond, Inc." are "Drug" (26 trials), "Other" (4 trials), "Combination Product" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Inhaled Treprostinil" (4 trials), "Salmeterol" (3 trials), "Blood Sample Collection" (2 trials) and "Inhaled treprostinil solution" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Associates of Richmond, Inc." are 33 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary Associates of Richmond, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Pulmonary Associates of Richmond, Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Associates of Richmond, Inc., 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".